Effects of Bushen Huoxue Yin on brain NF-κB and NO content in the parkinson's disease model mouse

Journal of Traditional Chinese Medicine

Volumn 32, Issue 1, 2012, Pages 67-70

  Li, Shao Dan ^a   Liu, Yi ^a   Yang, Ming Hui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Bushen Huoxue Yin; Nitric oxide; Nuclear transcription factor kappa B; Parkinson's disease; Therapy of Traditional Chinese Medicine

Indexed keywords

ANTIPARKINSON AGENT; BUSHEN HUOXUE YIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN TISSUE; CELL PROLIFERATION; CHINESE MEDICINE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DOPAMINERGIC NERVE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPECTROPHOTOMETRY;

EID: 84861436834     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(12)60034-x     Document Type: Article

References (20)

1. Yang MH, Li JY, Liu Y. System theory guiding the thinking of treatment for Parkinson's disease. Medicine and Philosophy 2009; 30: 3-5.
2. Yang MH, Dou YQ, Liu Y, Zhao GY, Luo Y. Clinical control observation on Yichan Decoction for treatment of Parkinson's disease. China Journal of Integrated Chinese Medicine and Western Medicine for Emergency Treatment 2002; 9: 256-257.
3. Yang MH, Li M, Dou YQ, Liu Y, Luo XD, Chen JZ, Shi HJ. Effects of Bushen Huoxue Granules on motor function in the patient of Parkinson's disease: A control study of multi-centers, randomization, double blind method and placebo. Acta of Integrated Chinese Medicine and Western Medicine 2010; 8: 31-37.
4. Yang MH, Wang HM, Liu Y. Effects of Yichan Decoction on dopamine receptor and neurotensin content of the brain in the rat of Parkinson's disease. China Journal of Integrated Chinese Medicine and Western Medicine for Emergency Treatment 2008; 15: 71-73.
5. Yang MH, Wang HM, Liu Y. Effect of Bushen Huoxue Yin on brain DAT in the PD rat. Chinese Journal of Traditional Chinese Medicine and Pharmacy 2009; 27: 677-678.
6. Yang XX, Yang L, Huo QL, Liu MN, Lin XX, Liu SJ. Effects of Qing Xuan Tablets on behaviors and tumor necrosis factor in striatum in the Parkinson's disease model mouse. Chinese Medical Materials 2009; 32: 1560-1563.
7. Ogawa N, Hirose Y, Ohara S, Ono T, Watanabe Y. A simple quantitative bradykinesia test in MPTP-treated mice. Res Commun Chem Pathol Pharmacol 1985; 50: 435-441.
8. Kawai H, Makino Y, Hirobe M. Novel endogenous 1, 2, 3, 4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism. J Neurochem 1998; 70: 745-751.
9. Mei CJ, Ma L, Xu HR, Sun SH. Effect of acupuncture at Jiaji points on behaviors and brain NO content in the Parkinson's disease mouse. Information of Traditional Chinese Medicine and Pharmacy 2010; 27: 74-76.
10. Klivenyi P, Andreassen GA, Ferrante RJ, Lancelot, E Reif, D Beal, MF. Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. Neuroreport 2000; 11: 1265-1268.
11. Dauer W, Przedborski S. Parkinson's Disease: Mechanisms and Models. Neuron 2003: 889-909.
12. Soos J, Engelhardt J I, Siklos L, Havas L Majtenyi K. The expression of PARP, NF-kappa B and parvalbumin is increased in Parkinson disease. Neuroreport 2004; 15: 1715-1718.
13. Li XF, Chen JZ. NO signal pathway and pathogenesis of Parkinson's disease. Journal of The Fourth Military Medical University 2009; 30: 1836-1838.
14. Kaushal V, Schlichter LC. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci 2008; 28: 2221-2230.
15. D'Acquisto F, Ianaro A. From willow bark to peptides: the ever widening spectrum of NF-kappa B inhibitors. Curr Opin Pharmacol 2006; 6: 387-392.
16. Puisieux F, Deplanque D, Bulckaen H, Maboudou P, Gele P, Lhermitte M, Lebuffe G, Bordet R. Brain ischemic preconditioning is abolished by antioxidant drugs but does not up-regulate superoxide dismutase and glutathione peroxidase. Brain Res 2004; 1027: 30-37.
17. Davies IR, Zhang X. Nitric oxide selective electrodes. Methods Enzymol 2008; 436: 63-95.
18. Yang MH, Dou YQ, Liu Y. Effect of Yichan Decoction on behaviors and cellular pharmacology of substantia nigra in the Parkinson's disease model rat. China Journal of Integrated Chinese Medicine and Western Medicine 2002; 22: 841-843.
19. Yang MH, Dou YQ, Liu Y. Yichan Decoction on M and dopamine receptors and catecholamines in the Parkinson's disease model rat. Journal of Traditional Chinese Medicine 2003; 21: 463-464.
20. Guo Z, Shao L, Du Q. Identification of a classic cytokine- induced enhancer up stream in the human iNOS promoter. FASEB J 2007; 21: 535-542.